Efficacy and Tolerability of Travoprost 0.004/Timolol 0.5 Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy

Figure 4

Percentage of patients achieving IOP ≤ 18 mmHg at week 4 and week 8 (total population) and by region (ITT population). ^#At week 8, both groups were receiving TTFC, as patients in the beta-blocker group had switched to TTFC between week 5 and week 8. IOP, intraocular pressure; ITT, intent-to-treat; TTFC, travoprost 0.004%/timolol 0.5% fixed-dose combination.